@article{b78d5824d917442889dc550b676b11b0,
title = "Oxytocin in schizophrenia: Pathophysiology and implications for future treatment",
abstract = "Schizophrenia is a form of mental disorder that is behaviorally characterized by abnormal behavior, such as social function deficits or other behaviors that are disconnected from reality. Dysregulation of oxytocin may play a role in regulating the expression of schizophrenia. Given ox-ytocin{\textquoteright}s role in social cognition and behavior, a variety of studies have examined the potential clinical benefits of oxytocin in improving the psychopathology of patients with schizophrenia. In this review, we highlight the evidence for the role of endogenous oxytocin in schizophrenia, from animal models to human studies. We further discuss the potential of oxytocin as a therapeutic agent for schizophrenia and its implication in future treatment.",
keywords = "Oxytocin, Psychopathology, Schizophrenia, Social cognition",
author = "Goh, {Kah Kheng} and Chen, {Chun Hsin} and Lane, {Hsien Yuan}",
note = "Funding Information: Funding: The authors disclose receipt of the following financial support for the research, authorship, and/or publication of this article: this study was supported by the Wan-Fang Hospital, Taipei Medical University (110-eva-13); the Higher Education Sprout Project by the Ministry of Education; the Ministry of Science and Technology (MOST108-2314-B-038-077, MOST109-2314-B-038-084, MOST109-2314-B-038-023-MY2), Taiwan; China Medical University (CMU109-MOST-03). Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2021",
month = feb,
day = "2",
doi = "10.3390/ijms22042146",
language = "English",
volume = "22",
pages = "1--26",
journal = "International journal of molecular sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",
}
